MRP5 Inhibitors

MRP5 inhibitors belong to a specialized chemical class of compounds designed to specifically target MRP5, also known as Multidrug Resistance Protein 5. MRP5 is a member of the ATP-binding cassette (ABC) transporter family and is involved in the efflux of various molecules, including toxins, from cells. It is expressed in various tissues, including the liver, kidney, and intestines. Researchers explore various strategies to inhibit MRP5, including small molecule compounds and nucleic acid-based approaches. High-throughput screening of compound libraries is used to identify novel MRP5 inhibitors. Additionally, RNA interference and CRISPR/Cas9 gene-editing techniques are employed to investigate the effects of reducing or disrupting MRP5 expression. Combinatorial approaches, such as combining MRP5-targeting compounds with other agents, might also be explored to enhance their effectiveness.